Table 1 Patient characteristics.
| Â | Baseline | At time of switch to sorafenib |
|---|---|---|
Number of patients | 15 | 9 |
Median age (range) in yrs | 58 (39-80) | Â |
Gender, n | Â | Â |
   Male | 11 |  |
   Female | 4 |  |
ECOG Performance status, n | Â | Â |
   0-1 | 7 |  |
   2 | 4 |  |
   3 | 3 |  |
   4 | 0 |  |
Previous nephrectomy, n | 14 | Â |
No. of disease sites, n | Â | Â |
   1 | 0 |  |
   2 | 10 |  |
   > = 3 | 45 |  |
Metastatic sites, n | Â | Â |
   Lung | 7 |  |
   Lymph nodes | 3 |  |
   Bone | 4 |  |
   Peritoneum | 4 |  |
   Pancreas | 1 |  |
   Liver | 5 |  |
   CNS | 1 |  |